ATE137671T1 - Verfahren zur konditionierung wasserlöslicher substanzen - Google Patents

Verfahren zur konditionierung wasserlöslicher substanzen

Info

Publication number
ATE137671T1
ATE137671T1 AT92907877T AT92907877T ATE137671T1 AT E137671 T1 ATE137671 T1 AT E137671T1 AT 92907877 T AT92907877 T AT 92907877T AT 92907877 T AT92907877 T AT 92907877T AT E137671 T1 ATE137671 T1 AT E137671T1
Authority
AT
Austria
Prior art keywords
water soluble
soluble substances
conditioning water
vacuum
micronised
Prior art date
Application number
AT92907877T
Other languages
English (en)
Inventor
Jan Trofast
Eva Trofast
Katarina Bystroem
Edib Jakupovic
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE137671(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of ATE137671T1 publication Critical patent/ATE137671T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Paper (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Treating Waste Gases (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Hydrogenated Pyridines (AREA)
AT92907877T 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen ATE137671T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
ATE137671T1 true ATE137671T1 (de) 1996-05-15

Family

ID=20382434

Family Applications (2)

Application Number Title Priority Date Filing Date
AT92907877T ATE137671T1 (de) 1991-04-11 1992-03-24 Verfahren zur konditionierung wasserlöslicher substanzen
AT95111178T ATE208613T1 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche substanzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT95111178T ATE208613T1 (de) 1991-04-11 1992-03-24 Konditionierte wasserlösliche substanzen

Country Status (28)

Country Link
US (1) US5562923A (de)
EP (3) EP0508969A1 (de)
JP (2) JP3400999B2 (de)
KR (1) KR100216384B1 (de)
AT (2) ATE137671T1 (de)
AU (1) AU662519B2 (de)
BG (1) BG61474B1 (de)
CA (1) CA2106975C (de)
CZ (1) CZ286936B6 (de)
DE (2) DE69210601T2 (de)
DK (2) DK0580648T3 (de)
EE (1) EE02970B1 (de)
ES (2) ES2168322T3 (de)
FI (1) FI105388B (de)
GR (1) GR3020602T3 (de)
HK (1) HK52497A (de)
HU (1) HU211116B (de)
IE (1) IE921144A1 (de)
IS (1) IS3834A (de)
NO (1) NO311867B1 (de)
PL (1) PL168232B1 (de)
PT (1) PT680752E (de)
RO (1) RO115779B1 (de)
RU (1) RU2112507C1 (de)
SE (1) SE9101090D0 (de)
SG (1) SG43180A1 (de)
SK (1) SK280310B6 (de)
WO (1) WO1992018110A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
DE69624559T2 (de) * 1995-02-28 2003-07-10 Aventis Pharmaceuticals Inc., Bridgewater Arzneizubereitungen für piperidinalkanolderivate
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
EP0969816B1 (de) * 1997-03-20 2004-12-15 Schering Corporation Herstellung von pulveragglomeraten
DK0998272T3 (da) * 1997-08-26 2003-08-25 Aventis Pharma Inc Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
KR100575070B1 (ko) * 1997-09-29 2006-05-03 넥타르 테라퓨틱스 안정화된 생활성 제제 및 이의 사용 방법
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826284D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826286D0 (en) * 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
CA2519779A1 (en) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. A process for preparing a pharmaceutical active ingredient with high specific surface area
DK1820494T3 (da) * 2003-06-13 2010-05-25 Skendi Finance Ltd Mikropartikler bestående af estradiol og cholesterol
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
BRPI0415579A (pt) * 2003-10-17 2007-01-02 Du Pont estrutura em multicamadas, embalagem e processo
JP2007520546A (ja) 2004-02-03 2007-07-26 ケマジス リミティド モンテルカストナトリウムの安定な非晶質性形態
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
EP2234595B1 (de) * 2007-12-13 2012-11-28 Novartis AG Verfahren zur Verringerung der Neigung eines Glycopyrroniumsalzes während der Lagerung. zu aggregieren.
RU2376079C1 (ru) * 2008-06-11 2009-12-20 Государственное образовательное учреждение высшего профессионального образования "Московский государственный университет инженерной экологии" Способ получения порошков микронизированных частиц
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
EP2726464A1 (de) 2011-06-29 2014-05-07 Astrazeneca AB Kristalline form von indazolylamidderivaten zur behandlung glucocorticoidrezeptor-vermittelten erkrankungen
BR112015022784B1 (pt) * 2013-03-15 2023-02-14 Pearl Therapeutics, Inc Método de condicionamento de material cristalino micronizado e sistemas de condicionamento
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
WO1986007547A1 (fr) * 1985-06-21 1986-12-31 Gerhard Gergely Procede et dispositif pour la manipulation de materiau de traitement et le produit de reaction fabrique a l'aide du procede et/ou du dispositif
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
JP3025528B2 (ja) * 1989-11-24 2000-03-27 ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング パンクレアチン製剤
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
SK108893A3 (en) 1994-03-09
CA2106975A1 (en) 1992-10-12
US5562923A (en) 1996-10-08
AU662519B2 (en) 1995-09-07
PL168232B1 (pl) 1996-01-31
DE69210601T2 (de) 1996-10-02
HUT65095A (en) 1994-04-28
EP0508969A1 (de) 1992-10-14
NO311867B1 (no) 2002-02-11
IS3834A (is) 1992-10-12
EP0580648B1 (de) 1996-05-08
HU211116B (en) 1995-10-30
EP0580648A1 (de) 1994-02-02
SG43180A1 (en) 1997-10-17
NO933575L (no) 1993-10-06
JP2003155228A (ja) 2003-05-27
ES2086733T3 (es) 1996-07-01
BG98147A (bg) 1994-12-02
BG61474B1 (en) 1997-09-30
JP3400999B2 (ja) 2003-04-28
FI105388B (fi) 2000-08-15
SK280310B6 (sk) 1999-11-08
EP0680752B1 (de) 2001-11-14
GR3020602T3 (en) 1996-10-31
HU9302870D0 (en) 1993-12-28
DE69232207T2 (de) 2002-08-01
JPH06506454A (ja) 1994-07-21
IE921144A1 (en) 1992-10-21
DE69210601D1 (de) 1996-06-13
RO115779B1 (ro) 2000-06-30
DK0580648T3 (da) 1996-09-16
CZ286936B6 (cs) 2000-08-16
DE69232207D1 (de) 2001-12-20
ATE208613T1 (de) 2001-11-15
AU1534792A (en) 1992-11-17
EE02970B1 (et) 1997-04-15
NO933575D0 (no) 1993-10-06
WO1992018110A1 (en) 1992-10-29
CZ211693A3 (en) 1994-04-13
DK0680752T3 (da) 2002-02-25
FI934429L (fi) 1993-10-08
ES2168322T3 (es) 2002-06-16
CA2106975C (en) 2002-03-19
HK52497A (en) 1997-05-02
EP0680752A2 (de) 1995-11-08
EP0680752A3 (de) 1995-11-22
FI934429A0 (fi) 1993-10-08
RU2112507C1 (ru) 1998-06-10
SE9101090D0 (sv) 1991-04-11
KR100216384B1 (ko) 1999-08-16
PT680752E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
ATE137671T1 (de) Verfahren zur konditionierung wasserlöslicher substanzen
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
CA2211600A1 (en) Apparatus for and method of testing leakage of hollow member
MX166765B (es) Metodo para esterilizar superficies contaminadas microbiologicamente a temperaturas y humedades ambientales
ATE97411T1 (de) Verfahren zur herstellung von taxol.
KR830008995A (ko) 인체 인슐린 및 그의 유도체의 제조방법
ES2144868T3 (es) Metodo de tratamiento de superficie por via seca y dispositivo para la aplicacion de un metodo asi.
IT7924258A0 (it) Apparato e metodo per manovrare pneumatici non vulcanizzati.
DE69205050D1 (de) Verfahren zur Sorption von Restgasen, insbesondere von Stickstoff mittels eines nichtverdampfbaren Bariumgetters.
NO980861L (no) Granulat med risleevne og basert på organiske syrer, fremgangsmåte for fremstilling, samt anvendelse
DE59303465D1 (de) Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators
IL90242A0 (en) A process for drying water-wet polycarbonate membranes
SE8406387L (sv) Sperrhjulsanordning
DK0394734T3 (da) Fremgangsmåde og apparat til sterilisering af genstande ved hjælp af et gasformigt steriliseringsmiddel
ES479438A1 (es) Procedimiento de colocacion de un manguito de envainado.
EP0278515A3 (en) Chloramine removing means
JPS5259212A (en) Vehicle use air cleaner
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
NL7812663A (en) Polymeric filtration membranes - cast from solns. in water-immiscible solvents and immersed in alcohol bath, can be stored in the dry state
JPS5232042A (en) Method to prevent polyethylene cross-linked with organosilane from deg radation
JPS5348989A (en) Artificial kidney
JPS5216745A (en) Defect repair apparatus of symmetrical body
DK1059166T3 (da) Fremgangsmåde og apparat til tørring af trykte materialer
JPS51131552A (en) A coating method
JPS5235076A (en) Jig for automatic transporting apparatus of panels

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification